#
Apresoline Injection
  • Drugs A to Z
  • Apresoline (Injection)

Apresoline (Injection)

Generic name:hydralazine (injection route) [ hye-DRAL-a-zeen ]
Drug class:Vasodilators

Medically reviewed by Drugs.com. Last updated on Apr 12, 2022.

Commonly used brand name(s)

In the U.S.

  • Apresoline
  • Novaplus HydrALAZINE Hydrochloride

Available Dosage Forms:

  • Solution

Therapeutic Class: Peripheral Vasodilator

Uses for Apresoline

Hydralazine injection is used to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure can decrease the risk of heart attacks and strokes.

Hydralazine works by relaxing the blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload.

This medicine is to be given only by or under the direct supervision of your doctor.

Before using Apresoline

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies on the relationship of age to the effects of hydralazine injection have not been performed in the pediatric population. However, no pediatric-specific problems have been documented to date.

Geriatric

No information is available on the relationship of age to the effects of hydralazine injection in geriatric patients.

Breastfeeding

Studies in women suggest that this medication poses minimal ris...